Literature DB >> 1878151

[Angiotensin II receptors in the human placenta are type AT1].

M K Kalenga1, M de Gasparo, R de Hertogh, S Whitebread, L Vankrieken, K Thomas.   

Abstract

Membrane angiotensin II receptors were measured in human placenta by means of 125I [Sar1 Ile8] All (angiotensin II antagonist) and characterized by using 2 other antagonists of angiotensin II: Dup 753 and CGP 42112A. These are specific and selective ligands which enable identification of AT1 and AT2 receptor subtypes respectively. The [Sar1 Ile8] All affinity is similar (Kd approximately 1 nmol.l-1) in the 3 different placental structures examined. However, the Bmax of villous tissues is approximately 9 times higher than that observed in chorionic plate but remains near that found in basal plate. In the central area of the placenta, mean values of 125I [Sar1 Ile8] All binding observed at a single concentration of 0.15 nmol.l-1 are 242 +/- 31 fmol/mg proteins in basal plate, 300 +/- 35 in villous tissues and 36 +/- 8 in chorionic plate. The umbilical vein and arteries respectively have 8.8 +/- 4.8 and 4.0 +/- 1.7 fmol/mg protein. The subtype analysis shows that only AT1 receptor is present in placental tissues. The Bmax values as well as those obtained by the relative measurement performed at a fixed 125I [Sar1 Ile8] All concentration of 0.15 nmol.l-1 indicate that the highest concentrations of angiotensin II receptors are found in placental villous tissues.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1878151

Source DB:  PubMed          Journal:  Reprod Nutr Dev        ISSN: 0926-5287


  8 in total

Review 1.  Molecular biology of angiotensin receptors and their role in human cardiovascular disease.

Authors:  V Regitz-Zagrosek; M Neuss; J Holzmeister; C Warnecke; E Fleck
Journal:  J Mol Med (Berl)       Date:  1996-05       Impact factor: 4.599

Review 2.  Angiotensin II regulation of ovine fetoplacental artery endothelial functions: interactions with nitric oxide.

Authors:  Jing Zheng; Ian M Bird; Dong-Bao Chen; Ronald R Magness
Journal:  J Physiol       Date:  2005-03-24       Impact factor: 5.182

3.  Comparison of angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition in pregnant sheep during late gestation.

Authors:  A J Forhead; K Whybrew; P Hughes; F Broughton Pipkin; M Sutherland; A L Fowden
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

Review 4.  Interaction of SARS-CoV-2 With RAS / ACE2 in the Female Reproductive System.

Authors:  Farideh Zafari Zangeneh
Journal:  J Family Reprod Health       Date:  2022-03

5.  Distortion of maternal-fetal angiotensin II type 1 receptor allele transmission in pre-eclampsia.

Authors:  L Morgan; S Crawshaw; P N Baker; J F Brookfield; F Broughton Pipkin; N Kalsheker
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

6.  Vasoreactivity of chorionic plate arteries in response to vasoconstrictors produced by preeclamptic placentas.

Authors:  C Benoit; J Zavecz; Y Wang
Journal:  Placenta       Date:  2006-10-27       Impact factor: 3.481

Review 7.  Local Renin-Angiotensin system in the reproductive system.

Authors:  Daniel Herr; Inga Bekes; Christine Wulff
Journal:  Front Endocrinol (Lausanne)       Date:  2013-10-18       Impact factor: 5.555

8.  Species-specific pharmacology of maximakinin, an amphibian homologue of bradykinin: putative prodrug activity at the human B2 receptor and peptidase resistance in rats.

Authors:  Xavier Charest-Morin; Hélène Bachelard; Melissa Jean; Francois Marceau
Journal:  PeerJ       Date:  2017-01-18       Impact factor: 2.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.